Heart pump support for high-risk angioplasty
Part of Heart & circulation clinical trials.
This trial tests the iVAC 2L device, a temporary heart pump placed in the main artery, to help patients who need a high-risk angioplasty (PCI) because of a very narrowed or blocked coronary artery. The goal is to prevent the heart from failing during the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your heart team has decided that your angioplasty has a high risk of causing your heart to collapse.
- You have signed a consent form to participate in the study.
- The artery in your groin (femoral artery) must be at least 6 millimeters wide.
- You cannot have heart failure involving both sides of the heart or mainly the right side.
- You must not have a blood clot in the left lower heart chamber, a mechanical heart valve, or severe aortic valve disease.
- You cannot have severe peripheral artery disease that would block the placement of the pump.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device called Ventiflow LP that supports the heart during high-risk stent placement (PCI) in people whose hearts are weak or have complex blockages. It may be an option if surgery is too risky or you prefer not to have it.
This trial tests a temporary heart pump (called the KARDION Cory P4) used during a high-risk angioplasty (stenting) procedure. The pump helps keep blood flowing in patients whose heart is weak or who have complex blockages, aiming to make the procedure safer.
This trial tests a new device called the VentriCure that helps the heart pump blood. It is for people with severe coronary artery disease and a weak heart who cannot have bypass surgery or choose not to.
This trial is testing a temporary heart pump device that helps your heart pump blood when it's too weak to do its job. It's for people who have severe heart failure (cardiogenic shock) despite getting powerful medications to keep their heart working.
This trial tests whether using a temporary heart pump plus close monitoring improves recovery in people with severe heart failure after a heart attack, compared to standard care.
This trial tests a new device called the Supira system to support the heart during a high-risk procedure to open blocked arteries. It is for people who are stable enough to wait for the procedure (not in emergency or shock).
Hear when a new Ischemic Cardiovascular Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.